Scalaradial, a Dialdehyde‐Containing Marine Metabolite That Causes an Unexpected Noncovalent PLA2 Inactivation
暂无分享,去创建一个
Claudio N. Cavasotto | Claudio N Cavasotto | Assunta Napolitano | Agostino Casapullo | Maria Chiara Monti | Raffaele Riccio | A. Napolitano | C. Cavasotto | R. Riccio | A. Casapullo | M. C. Monti
[1] G. Cimino,et al. Identification of an intermediate in the reaction between polygodial and methylamine in biomimetic conditions , 1984 .
[2] L. Gomez‐Paloma,et al. The Molecular Mechanism of Bee Venom Phospholipase A2 Inactivation by Bolinaquinone , 2006, Chembiochem : a European journal of chemical biology.
[3] G. Cimino,et al. Further sesterterpenes from the spongeSpongia nitens: 12-epi-scalaradial and 12,18-diepi-scalaradial , 1979, Experientia.
[4] P. Scheuer,et al. Manoalide, an antibiotic sesterterpenoid from the marine sponge (polejaeff) , 1980 .
[5] D. Wilton,et al. Inhibition of secreted phospholipases A2 by annexin V. Competition for anionic phospholipid interfaces allows an assessment of the relative interfacial affinities of secreted phospholipases A2. , 1998, Biochimica et biophysica acta.
[6] K. Glaser,et al. Inactivation of bee venom phospholipase A2 by manoalide. A model based on the reactivity of manoalide with amino acids and peptide sequences. , 1987, Biochemical pharmacology.
[7] L. Gomez‐Paloma,et al. PLA2‐mediated catalytic activation of its inhibitor 25‐acetyl‐petrosaspongiolide M: serendipitous identification of a new PLA2 suicide inhibitor , 2004, FEBS letters.
[8] Claudio N. Cavasotto,et al. Ligand docking and structure-based virtual screening in drug discovery. , 2007, Current topics in medicinal chemistry.
[9] L. Parente. Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? , 2001, The Journal of rheumatology.
[10] D. Faulkner,et al. Phospholipase A2 inhibitors from marine organisms. , 1992, Journal of natural products.
[11] M. d’Ischia,et al. Reaction of polygodial with primary amines: an alternative explanation to the antifeedant activity1☆ , 1982 .
[12] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[13] L. Gomez‐Paloma,et al. The inactivation of phospholipase A2 by scalaradial: a biomimetic study by electrospray mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.
[14] E. Dennis,et al. The growing phospholipase A2 superfamily of signal transduction enzymes. , 1997, Trends in biochemical sciences.
[15] R. Abagyan,et al. Determinants of retinoid X receptor transcriptional antagonism. , 2004, Journal of medicinal chemistry.
[16] M. Lehr. Phospholipase A2 inhibitors in inflammation , 2001 .
[17] L. Gomez‐Paloma,et al. Chemistry and Biology of Anti-Inflammatory Marine Natural Products. Phospholipase A2 Inhibitors , 2005 .
[18] R. Jacobs,et al. Two-step inactivation of bee venom phospholipase A2 by scalaradial. , 1991, Biochemical pharmacology.
[19] L. Marshall,et al. Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide. , 1990, Biochemical pharmacology.
[20] Claudio N. Cavasotto,et al. Representing receptor flexibility in ligand docking through relevant normal modes. , 2005, Journal of the American Chemical Society.
[21] Claudio N. Cavasotto,et al. Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.
[22] D. Faulkner,et al. Chemical mechanism of inactivation of bee venom phospholipase A2 by the marine natural products manoalide, luffariellolide, and scalaradial , 1992 .
[23] P. Gopalakrishnakone,et al. Group IIA secretory phospholipase A2 stimulates exocytosis and neurotransmitter release in pheochromocytoma-12 cells and cultured rat hippocampal neurons , 2003, Neuroscience.
[24] D. Wilton. A continuous fluorescence displacement assay for the measurement of phospholipase A2 and other lipases that release long-chain fatty acids. , 1990, The Biochemical journal.
[25] G. Cimino,et al. 12-epi-scalarin and 12-epi-deoxoscalarin, Sesterterpenes from the sponge Spongia nitens. , 1977, Journal of the Chemical Society. Perkin transactions 1.
[26] K. Glaser,et al. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation. , 1989, Molecular pharmacology.
[27] P. Kovanen,et al. Phospholipase A(2) in vascular disease. , 2001, Circulation research.
[28] Ruben Abagyan,et al. Protein structure prediction by global energy optimization , 1997 .
[29] Claudio N. Cavasotto,et al. Conformational Sampling of Protein Flexibility in Generalized Coordinates: Application to Ligand Docking , 2005 .
[30] J. Balsinde,et al. Regulation and inhibition of phospholipase A2. , 1999, Annual review of pharmacology and toxicology.
[31] L. Gomez‐Paloma,et al. Further insights on the structural aspects of PLA(2) inhibition by gamma-hydroxybutenolide-containing natural products: a comparative study on petrosaspongiolides M-R. , 2004, Bioorganic & medicinal chemistry.
[32] K. Glaser,et al. Pharmacological characterization of the pseudopterosins: novel anti-inflammatory natural products isolated from the Caribbean soft coral, Pseudopterogorgia elisabethae. , 1998, Life sciences.
[33] L. Gomez‐Paloma,et al. Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-kappaB and other unidentified targets. , 2006, Current medicinal chemistry.
[34] W Pruzanski,et al. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. , 1989, The Journal of biological chemistry.
[35] G. Marino,et al. Molecular Basis of Phospholipase A2 Inhibition by Petrosaspongiolide M , 2002, Chembiochem : a European journal of chemical biology.
[36] N. C. Price,et al. The application of circular dichroism to studies of protein folding and unfolding. , 1997, Biochimica et biophysica acta.
[37] S. de Rosa,et al. A new scalarane sesterterpenoid from the marine sponge Cacospongia mollior. , 1994, Journal of Natural Products.
[38] L. Marshall,et al. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation. , 1994, The Journal of pharmacology and experimental therapeutics.
[39] A. Kleinfeld,et al. Continuous measurement of phospholipase A2 activity using the fluorescent probe ADIFAB. , 1995, Analytical biochemistry.
[40] P. Vadas,et al. Role of secretory phospholipases A2 in the pathobiology of disease. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[41] K. Glaser,et al. Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production. , 1995, Biochemical pharmacology.
[42] D. Wilton,et al. Comparison of the catalytic properties of phospholipase A2 from pancreas and venom using a continuous fluorescence displacement assay. , 1991, The Biochemical journal.
[43] Claudio N. Cavasotto,et al. Structure‐based identification of binding sites, native ligands and potential inhibitors for G‐protein coupled receptors , 2003, Proteins.